• Abbott reached agreements with three law firms to settle the Gill case, resolving about 2,000 additional preterm formula claims.
• Settlement totals about $670 million, avoiding continued appeals or paying about $600 million tied to the Gill judgment and interest.
• A St. Louis jury awarded $495 million in July 2024; an appeal filed in December 2024 was denied.
• Roughly 1,700 lawsuits remain pending, covering claims on behalf of about 12,700 infants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608201615PR_NEWS_USPR_____CG30830) on August 20, 2026, and is solely responsible for the information contained therein.